Its quite incredible how little analysts and commentators know about things they talk about!
- Forums
- ASX - By Stock
- CU6
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
0.45%
!
$2.25

Ann: First patient imaged in Phase III AMPLIFY trial, page-24
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.25 |
Change
0.010(0.45%) |
Mkt cap ! $719.8M |
Open | High | Low | Value | Volume |
$2.24 | $2.26 | $2.20 | $763.4K | 342.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 11786 | $2.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.26 | 12830 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11739 | 2.250 |
9 | 16517 | 2.240 |
9 | 97070 | 2.230 |
10 | 43163 | 2.220 |
9 | 80079 | 2.210 |
Price($) | Vol. | No. |
---|---|---|
2.260 | 12830 | 8 |
2.270 | 38854 | 11 |
2.280 | 23130 | 9 |
2.290 | 28361 | 6 |
2.300 | 30711 | 7 |
Last trade - 10.40am 18/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online